Inspire Medical Systems, Inc. (INSP)
Inspire Medical Systems, Inc. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Golden Valley, MN, US. The stock last traded at $58.01, down 1.89% on the session, giving a market capitalisation of $1.68B. On trailing twelve-month figures it carries a trailing P/E of 12.45, a net margin of 15.0%. Its beta of 0.67 implies it has historically moved less than the broad market.
Inspire Medical Systems, Inc. operates as a medical technology enterprise, concentrating on the development and commercialization of advanced, minimally intrusive therapies for patients diagnosed with obstructive sleep apnea (OSA) across both domestic U.S. and international markets. A cornerstone of its product portfolio is the Inspire system, an innovative neurostimulation solution that offers a safe and proven effective treatment for individuals experiencing moderate to severe forms of OSA. Additionally, the company is pioneering a novel, closed-loop technology designed to continuously track a patient's breathing patterns and administer mild stimulation to the hypoglossal nerve, thereby maintaining an open airway. Founded in 2007, Inspire Medical Systems maintains its corporate headquarters in Golden Valley, Minnesota.
Inspire Medical Systems, Inc. is most often compared with the following Healthcare names: